These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20363482)

  • 1. Infection after implantation of pulsatile mechanical circulatory support devices.
    Holman WL; Kirklin JK; Naftel DC; Kormos RL; Desvign-Nickens P; Camacho MT; Ascheim DD
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1632-1636.e2. PubMed ID: 20363482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
    Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK
    J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INTERMACS: interval analysis of registry data.
    Holman WL; Pae WE; Teutenberg JJ; Acker MA; Naftel DC; Sun BC; Milano CA; Kirklin JK
    J Am Coll Surg; 2009 May; 208(5):755-61; discussion 761-2. PubMed ID: 19476831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridge to transplant experience: factors influencing survival to and after cardiac transplant.
    Smedira NG; Hoercher KJ; Yoon DY; Rajeswaran J; Klingman L; Starling RC; Blackstone EH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1295-305, 1305.e1-4. PubMed ID: 20412961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation.
    Alba AC; Rao V; Ivanov J; Ross HJ; Delgado DH
    J Heart Lung Transplant; 2009 Aug; 28(8):827-33. PubMed ID: 19632580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival results after implantation of intrapericardial third-generation centrifugal assist device: an INTERMACS-matched comparison analysis.
    Dell'Aquila AM; Schneider SR; Stypmann J; Ellger B; Redwan B; Schlarb D; Martens S; Sindermann JR
    Artif Organs; 2014 May; 38(5):383-90. PubMed ID: 24117675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.
    Crow S; John R; Boyle A; Shumway S; Liao K; Colvin-Adams M; Toninato C; Missov E; Pritzker M; Martin C; Garry D; Thomas W; Joyce L
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):208-15. PubMed ID: 19154927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances).
    Kirklin JK; Holman WL
    Curr Opin Cardiol; 2006 Mar; 21(2):120-6. PubMed ID: 16470148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)-defined morbidity and mortality associated with pediatric ventricular assist device support at a single US center: the Stanford experience.
    Stein ML; Robbins R; Sabati AA; Reinhartz O; Chin C; Liu E; Bernstein D; Roth S; Wright G; Reitz B; Rosenthal D
    Circ Heart Fail; 2010 Nov; 3(6):682-8. PubMed ID: 20807863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.
    Schenk S; McCarthy PM; Blackstone EH; Feng J; Starling RC; Navia JL; Zhou L; Hoercher KJ; Smedira NG; Fukamachi K
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):447-54. PubMed ID: 16434277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators.
    Farrar DJ
    J Heart Lung Transplant; 1994; 13(1 Pt 1):93-100; discussion 100-1. PubMed ID: 8167132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal timing of cardiac transplantation after ventricular assist device implantation.
    Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular accidents in patients with a ventricular assist device.
    Tsukui H; Abla A; Teuteberg JJ; McNamara DM; Mathier MA; Cadaret LM; Kormos RL
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):114-23. PubMed ID: 17599496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.